U.S. Markets closed

If You Had Bought WuXi Biologics (Cayman) (HKG:2269) Stock A Year Ago, You Could Pocket A 63% Gain Today

Simply Wall St

If you want to compound wealth in the stock market, you can do so by buying an index fund. But investors can boost returns by picking market-beating companies to own shares in. For example, the WuXi Biologics (Cayman) Inc. (HKG:2269) share price is up 63% in the last year, clearly besting the market return of around 3.5% (not including dividends). That's a solid performance by our standards! Note that businesses generally develop over the long term, so the returns over the last year might not reflect a long term trend.

See our latest analysis for WuXi Biologics (Cayman)

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

During the last year WuXi Biologics (Cayman) grew its earnings per share (EPS) by 95%. It's fair to say that the share price gain of 63% did not keep pace with the EPS growth. Therefore, it seems the market isn't as excited about WuXi Biologics (Cayman) as it was before. This could be an opportunity. Of course, with a P/E ratio of 114.91, the market remains optimistic.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

SEHK:2269 Past and Future Earnings, October 28th 2019

It is of course excellent to see how WuXi Biologics (Cayman) has grown profits over the years, but the future is more important for shareholders. This free interactive report on WuXi Biologics (Cayman)'s balance sheet strength is a great place to start, if you want to investigate the stock further.

A Different Perspective

It's nice to see that WuXi Biologics (Cayman) shareholders have gained 63% over the last year. The more recent returns haven't been as impressive as the longer term returns, coming in at just 3.5%. It seems likely the market is waiting on fundamental developments with the business before pushing the share price higher (or lower). If you would like to research WuXi Biologics (Cayman) in more detail then you might want to take a look at whether insiders have been buying or selling shares in the company.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on HK exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.